Navigating blindness: simple program aims to save sight in diabetics

NCT ID NCT05188703

Completed Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tested whether a patient navigator—a person who helps coordinate medical care—could increase eye exam rates in 35 adults with diabetes who were at high risk for blindness. Participants met with a navigator quarterly to overcome barriers to care. The study measured how many completed baseline and follow-up eye exams, aiming to see if this approach is feasible for a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Patient navigation (behavioral intervention)
What this could lead to: If successful, this approach could help more people with diabetes get regular eye exams, potentially preventing blindness from diabetic retinopathy.
What could go wrong: This is a small pilot study with only 35 participants, so results may not apply to everyone. The intervention is about scheduling and follow-up, not a medical treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC BLINDNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic retinopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC BLINDNESS DIABETIC RETINOPATHY

Contacts and locations

Locations

Yale School of Medicine

New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.